Adverse reactions to vancomycin used as prophylaxis for CSF shunt procedures

Research output: Contribution to journalArticle

74 Citations (Scopus)

Abstract

From January to May 1982, 37 children undergoing CSF shunt procedures in two different countries were enrolled in a randomized, double-blind, controlled study to receive vancomycin hydrochloride (15 mg/kg/dose) or placebo (saline) one hour before surgery and again six hours later. Twenty patients received vancomycin, and 17 received placebo. In the 35 cases that could be evaluated, shunt-associated infections developed in three (17%) of 18 patients who received vancomycin and in four (23%) of the 17 placebo recipients. All infections were caused by Staphylococcus species susceptible to vancomycin. A histaminelike rash developed in seven (35%) of 20 patients during vancomycin infusion. It recurred with readministration in one patient and was accompanied by hypotension in another patient. The reactions were not related to too rapid infusion of vancomycin. Because of the adverse reactions to vancomycin, the study was discontinued.

Original languageEnglish (US)
Pages (from-to)17-19
Number of pages3
JournalAmerican Journal of Diseases of Children
Volume138
Issue number1
StatePublished - 1984

Fingerprint

Vancomycin
Placebos
Infection
Exanthema
Staphylococcus
Double-Blind Method
Hypotension

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Adverse reactions to vancomycin used as prophylaxis for CSF shunt procedures. / Odio, C.; Mohs, E.; Sklar, F. H.; Nelson, J. D.; McCracken, G. H.

In: American Journal of Diseases of Children, Vol. 138, No. 1, 1984, p. 17-19.

Research output: Contribution to journalArticle

@article{917e73ac95e1434090a361a94fd8fe23,
title = "Adverse reactions to vancomycin used as prophylaxis for CSF shunt procedures",
abstract = "From January to May 1982, 37 children undergoing CSF shunt procedures in two different countries were enrolled in a randomized, double-blind, controlled study to receive vancomycin hydrochloride (15 mg/kg/dose) or placebo (saline) one hour before surgery and again six hours later. Twenty patients received vancomycin, and 17 received placebo. In the 35 cases that could be evaluated, shunt-associated infections developed in three (17{\%}) of 18 patients who received vancomycin and in four (23{\%}) of the 17 placebo recipients. All infections were caused by Staphylococcus species susceptible to vancomycin. A histaminelike rash developed in seven (35{\%}) of 20 patients during vancomycin infusion. It recurred with readministration in one patient and was accompanied by hypotension in another patient. The reactions were not related to too rapid infusion of vancomycin. Because of the adverse reactions to vancomycin, the study was discontinued.",
author = "C. Odio and E. Mohs and Sklar, {F. H.} and Nelson, {J. D.} and McCracken, {G. H.}",
year = "1984",
language = "English (US)",
volume = "138",
pages = "17--19",
journal = "JAMA Pediatrics",
issn = "2168-6203",
publisher = "American Medical Association",
number = "1",

}

TY - JOUR

T1 - Adverse reactions to vancomycin used as prophylaxis for CSF shunt procedures

AU - Odio, C.

AU - Mohs, E.

AU - Sklar, F. H.

AU - Nelson, J. D.

AU - McCracken, G. H.

PY - 1984

Y1 - 1984

N2 - From January to May 1982, 37 children undergoing CSF shunt procedures in two different countries were enrolled in a randomized, double-blind, controlled study to receive vancomycin hydrochloride (15 mg/kg/dose) or placebo (saline) one hour before surgery and again six hours later. Twenty patients received vancomycin, and 17 received placebo. In the 35 cases that could be evaluated, shunt-associated infections developed in three (17%) of 18 patients who received vancomycin and in four (23%) of the 17 placebo recipients. All infections were caused by Staphylococcus species susceptible to vancomycin. A histaminelike rash developed in seven (35%) of 20 patients during vancomycin infusion. It recurred with readministration in one patient and was accompanied by hypotension in another patient. The reactions were not related to too rapid infusion of vancomycin. Because of the adverse reactions to vancomycin, the study was discontinued.

AB - From January to May 1982, 37 children undergoing CSF shunt procedures in two different countries were enrolled in a randomized, double-blind, controlled study to receive vancomycin hydrochloride (15 mg/kg/dose) or placebo (saline) one hour before surgery and again six hours later. Twenty patients received vancomycin, and 17 received placebo. In the 35 cases that could be evaluated, shunt-associated infections developed in three (17%) of 18 patients who received vancomycin and in four (23%) of the 17 placebo recipients. All infections were caused by Staphylococcus species susceptible to vancomycin. A histaminelike rash developed in seven (35%) of 20 patients during vancomycin infusion. It recurred with readministration in one patient and was accompanied by hypotension in another patient. The reactions were not related to too rapid infusion of vancomycin. Because of the adverse reactions to vancomycin, the study was discontinued.

UR - http://www.scopus.com/inward/record.url?scp=0021343245&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021343245&partnerID=8YFLogxK

M3 - Article

VL - 138

SP - 17

EP - 19

JO - JAMA Pediatrics

JF - JAMA Pediatrics

SN - 2168-6203

IS - 1

ER -